Pfizer/Pharmacia Merger Review: Firms Expect Second Request From FTC
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission's review of the Pfizer/Pharmacia merger should progress relatively smoothly because the same FTC reviewers worked with Pfizer on the Warner-Lambert deal, CEO Hank McKinnell told the Bear Stearns healthcare conference in New York Sept. 17